04:00
2026-07-17
techfundingnews.com
artificial-intelligence
Reversing AI drug discovery: Belgian biotech Sightera raises €3M to learn from ‘extreme’ patient biology first
Belgian biotech Sightera raised €3 million to reverse the typical AI drug discovery process by first analyzing extreme patient biology to identify novel drug targets. The company's approach aims to im…